CLBT – cellebrite di ltd. - ordinary shares (US:NASDAQ)
Stock Stats
News
Cellebrite Completes Acquisition of Corellium, Extending the Industry’s Most Advanced AI-Powered Digital Investigation Platform
Cellebrite DI (NASDAQ:CLBT) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
How Do Cellebrite DI's New Partnerships Impact Its Value After a 19.8% Price Jump? [Yahoo! Finance]
Cellebrite (CLBT) Jumps 20.7% on Stellar Q3 [Yahoo! Finance]
Cellebrite DI (NASDAQ:CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $23.00 to $24.00. They now have an "overweight" rating on the stock.
Form 144 Cellebrite DI Ltd. Filed by: Shapira Ayala Berler
Form 6-K Cellebrite DI Ltd. For: Dec 02
Form 144 Cellebrite DI Ltd. Filed by: GEE DAVID NICHOLAS
Form 144 Cellebrite DI Ltd. Filed by: GEE DAVID NICHOLAS
Form 144 Cellebrite DI Ltd. Filed by: Gruber Dafna
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.